Patent US3569721A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3569721A Expired / Lapsed US ⏱️ 0.0 years remaining

Measuring bilirubin in blood using light at two wavelengths

Assignee: American Optical Corp
•
Filing: 1969-01-13
•
Granted: 1971-03-09
•
Expires: 1989-01-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Measuring the concentration of bilirubin in unmodified blood serum by defining the light transmission of a microsample of the serum in terms of bilirubin concentration at two preselected specific wavelengths of light wherein the effect of hemoglobin on transmission through the sample is eliminated.

Inventors

  • 👤 Herbert E Goldberg
  • 👤 Michael L Polanyi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 19:07
CPC Classifications
G; G01; G01N; G01N21/00; G01N21/17; G01N21/25; G01N21/31; G01N21/314

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 226 words
A method of measuring the concentration of bilirubin in blood serum comprising the steps of: directing light rays through a sample of said serum and forming said light rays into a beam of light directed along an established principal optical path; dividing said light rays of said beam into two substantially equal amounts at one point in said principal optical path and directing each of said equal amounts of light rays along a different discrete branch path wherein the total amount of light in each branch path is equal; filtering at one point in one of said branch paths substantially all wavelengths of the light therein but that for which bilirubin in serum has a maximum absorbance; filtering at one point in the other of said branch paths substantially all wavelengths of the light therein but that for which hemoglobin in blood serum has substantially the same absorbance as it has for the light of said first-mentioned wavelength, said first and last-mentioned wavelengths of light being of different frequencies; and adjusting the amount of light of one of said frequencies to equality with the amount of light of different frequency by operation of adjustable aperture stop means disposed in one of said branch paths whereby the extent of adjustment of said stop means may be interpreted in terms of the concentration of bilirubin in said sample.
Claim 2
Independent Claim 226 words
A method of measuring the concentration of bilirubin in blood serum comprising the steps of: directing light rays through a sample of said serum and forming said light rays into a beam of light directed along an established principal optical path; dividing said light rays of said beam into two substantially equal amounts at one point in said principal optical path and directing each of said equal amounts of light rays along a different discrete branch path wherein the total amount of light in each branch path is equal; filtering at one point in one of said branch paths substantially all wavelengths of the light therein but that for which bilirubin in serum has a maximum absorbance; filtering at one point in the other of said branch paths substantially all wavelengths of the light therein but that for which hemoglobin in blood serum has substantially the same absorbance as it has for the light of said first-mentioned wavelength, said first and last-mentioned wavelengths of light being of different frequencies; and adjusting the amount of light of one of said frequencies to equality with the amount of light of different frequency by operation of adjustable aperture stop means disposed in one of said branch paths whereby the extent of adjustment of said stop means may be interpreted in terms of the concentration of bilirubin in said sample.
Claim 3
Dependent Claim 21 words
The method according to claim 1 wherein said first and last-mentioned wavelengths of light are 461 Mu and 551 Mu respectively.
Claim 4
Dependent Claim 23 words
The method according to claim 2 wherein said light of different frequencies is adjusted by attenuation of the light of 551 Mu wavelength.
Claim 5
Dependent Claim 37 words
The method according to claim 2 wherein said light of different frequencies is adjusted by increasing the amount of said light of 461 Mu wavelength with respect to the amount of said light of 551 Mu wavelength.
Claim 6
Independent Claim 268 words
A system for measuring the concentration of bilirubin in a sample of blood serum comprising: a source of light; a sample holder positioned to receive light rays emitted by said source wherewith a blood sample placed in said holder is transilluminated; projection lens means arranged to receive at least a substantial amount of said light rays transmitted through said holder and sample for forming and prOjecting a beam thereof along a principal optical path in said system; a beam splitter in said principal path constructed and arranged to divide said light rays of said beam into two parts of substantially equal amounts and direct each part discretely along an individual branch path; a band-pass filter in each branch path through which substantially only light rays of one wavelength are permitted to pass; an electrical photodetector so positioned in each branch path as to receive only respective light rays of the one wavelength; projection lens means between said photodetector and band-pass filter in each branch path for receiving and directing said light rays into incidence upon respective photodetectors in said paths; an adjustable light attenuator in one of said branch paths for regulating the amount of light rays received by the particular photodetector in said one path; a meter for indicating relative electrical responses of said photodetectors to light rays received thereby; and a scale moveable in conjunction with adjustment of said attenuator, said scale being calibrated to read bilirubin concentration in terms of the amount of regulation of light effected by operation of said attenuator for a given indication of relative responses of said photodetectors on said meter.
Claim 7
Independent Claim 268 words
A system for measuring the concentration of bilirubin in a sample of blood serum comprising: a source of light; a sample holder positioned to receive light rays emitted by said source wherewith a blood sample placed in said holder is transilluminated; projection lens means arranged to receive at least a substantial amount of said light rays transmitted through said holder and sample for forming and prOjecting a beam thereof along a principal optical path in said system; a beam splitter in said principal path constructed and arranged to divide said light rays of said beam into two parts of substantially equal amounts and direct each part discretely along an individual branch path; a band-pass filter in each branch path through which substantially only light rays of one wavelength are permitted to pass; an electrical photodetector so positioned in each branch path as to receive only respective light rays of the one wavelength; projection lens means between said photodetector and band-pass filter in each branch path for receiving and directing said light rays into incidence upon respective photodetectors in said paths; an adjustable light attenuator in one of said branch paths for regulating the amount of light rays received by the particular photodetector in said one path; a meter for indicating relative electrical responses of said photodetectors to light rays received thereby; and a scale moveable in conjunction with adjustment of said attenuator, said scale being calibrated to read bilirubin concentration in terms of the amount of regulation of light effected by operation of said attenuator for a given indication of relative responses of said photodetectors on said meter.
Claim 8
Dependent Claim 44 words
The system according to claim 5 wherein one of said band-pass filters is transmissive substantially only to light rays having a wavelength of 461 Mu and the other band-pass filter is transmissive substantially only to light rays having a wavelength of 551 Mu .
Claim 9
Dependent Claim 21 words
The system according to claim 5 wherein said light attenuator is opaque with an elongated light-transmitting portion of progressively diminishing width.
Claim 10
Dependent Claim 15 words
The system according to claim 7 wherein said light-transmitting portion of said attenuator is annular.
Claim 11
Dependent Claim 44 words
The system according to claim 7 wherein the calibration of said scale is linear with the negative logarithm of the area of said light-transmitting portion of said light attenuator and said negative logarithm of said area is proportional to bilirubin concentration in blood serum.
Claim 12
Dependent Claim 66 words
The system according to claim 9 further including a reference standard having light-absorption characteristics similar to blood serum of low bilirubin concentration, means for temporarily substituting said standard for said specimen holder whereby a given ratio of responses of said photodetectors to said rays of 461 Mu and 551 Mu wavelengths may be established prior to operation of said system with said specimen holder in place.

References Cited (Backward Citations)

US2670223A Cited
US3081399A Cited
US3383515A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1974-03-08 1974-09-07 1975-03-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1978-03-08 1978-09-07 1979-03-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1982-03-08 1982-09-07 1983-03-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag